Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$10,725,994
-$321,744 QoQ
Shares Held
29,620
-5.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#525
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Linscomb Wealth, Inc. holds $62,600,297 across 7 Drug Manufacturers - General names. AMGN ranks #4 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,722 | $17,796,484 | |
| 2 | JNJ |
Johnson & Johnson
|
59,468 | $15,103,087 | |
| 3 | MRK |
Merck & Co., Inc.
|
92,395 | $11,872,757 | |
| 4 | AMGN |
Amgen Inc
This page
|
29,620 | $10,725,994 | |
| 5 | PFE |
Pfizer Inc
|
209,174 | $5,036,909 | |
| 6 | LLY |
ELI LILLY & Co
|
1,056 | $1,266,598 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,320 | $798,468 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,725,994 | 29,620 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $11,047,738 | 31,399 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $12,730,067 | 38,893 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $10,932,710 | 38,741 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $10,639,017 | 38,104 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $11,836,719 | 37,993 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,846,903 | 33,943 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $10,809,178 | 33,547 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $10,632,985 | 34,031 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $9,882,963 | 34,760 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,168,834 | 35,306 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $10,522,491 | 39,152 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $9,370,132 | 42,204 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,681,482 | 44,184 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $11,829,305 | 45,040 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,077,183 | 44,708 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $10,690,115 | 43,938 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,459,198 | 43,252 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $9,216,121 | 40,966 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,494,091 | 39,944 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $9,438,975 | 38,724 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $9,264,440 | 37,235 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $8,279,189 | 36,009 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $8,944,907 | 35,194 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,118,537 | 34,421 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $6,192,996 | 30,548 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||